Anthony Reffi

Dr. Anthony Reffi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2022 in SLEEP
Verified
Journal Article
Closed access
PDF file
DKDavid A Kalmbach
David A Kalmbach
PCPhilip Cheng
Philip Cheng
BABrian K Ahmedani
Brian K Ahmedani
EPEdward L Peterson
Edward L Peterson
ARAnthony Reffi
Anthony Reffi
Christopher Lawrence DrakeChristopher Lawrence Drake
Christopher Lawrence Drake
Insomnia is associated with elevated levels of suicidal thoughts and behaviors. Emerging evidence suggests that cognitive-behavioral therapy for insomnia (CBTI) may reduce suicidal ideation (SI). However, the role of digital therapeutics in both the alleviation and prevention of SI remains unclear, and treatment mechanisms facilitating SI reductions have not been clearly identified. A total of 658 adults with Diagnostic and Statistical Manual of Mental Disorders, 5th Edition insomnia disorder enrolled in a single-site randomized controlled trial evaluating the efficacy of digital CBTI relative to attention control. Outcomes were measured at pretreatment, posttreatment, and 1-year follow-up. Before treatment, 126 patients endorsed SI (19.1% prevalence). Among those with baseline SI, CBTI patients reported lower SI rates at posttreatment (30.0% vs 54.5%, p = .005) and 1-year follow-up (29.6% vs 46.8%, p = .042) relative to control. PRODCLIN analysis estimated that half of suicidolytic effects of CBTI were mediated through insomnia remission. Among those without baseline SI, CBTI did not directly prevent new onset SI. However, insomnia remitters reported lower rates of new-onset SI at posttreatment relative to non-remitters (1.5% vs 6.5%, p = .009). Mediation analysis supported a significant indirect effect wherein CBTI increased the likelihood of insomnia remission, which was associated with SI prevention (αβ = −3.20, 95% CI = −5.74 to −0.87). Digital CBTI reduces insomnia symptoms, which promotes SI alleviation and prevention. For nonsuicidal patients, digital CBTI may serve as a highly accessible monotherapy for improving sleep, thereby reducing the risk for SI. For suicidal patients, digital CBTI may be appropriately administered as an adjunct treatment to support mainline intervention more directly targeting suicidogenic thoughts.

6 February 2025 in European Journal of Psychotraumatology
Verified
Journal Article
Open access
MOMiranda Olff
Miranda Olff
IHIrma Hein
Irma Hein
AAAnanda B. Amstadter
Ananda B. Amstadter
CACherie Cherie Armour
Cherie Cherie Armour
MBMarianne Skogbrott Birkeland
Marianne Skogbrott Birkeland
AVAnka A Vujanovic
Anka A Vujanovic
To mark 15 years of the European Journal of Psychotraumatology, editors reviewed the past 15-year years of research on trauma exposure and its consequences, as well as developments in (early) psychological, pharmacological and complementary interventions. In all sections of this paper, we provide perspectives on sex/gender aspects, life course trends, and cross-cultural/global and systemic societal contexts. Globally, the majority of people experience stressful events that may be characterized as traumatic. However, definitions of what is traumatic are not necessarily straightforward or universal. Traumatic events may have a wide range of transdiagnostic mental and physical health consequences, not limited to posttraumatic stress disorder (PTSD). Research on genetic, molecular, and neurobiological influences show promise for further understanding underlying risk and resilience for trauma-related consequences. Symptom presentation, prevalence, and course, in response to traumatic experiences, differ depending on individuals' age and developmental phase, sex/gender, sociocultural and environmental contexts, and systemic socio-political forces. Early interventions have the potential to prevent acute posttraumatic stress reactions from escalating to a PTSD diagnosis whether delivered in the golden hours or weeks after trauma. However, research on prevention is still scarce compared to treatment research where several evidence-based psychological, pharmacological and complementary/ integrative interventions exist, and novel forms of delivery have become available. Here, we focus on how best to address the range of negative health outcomes following trauma, how to serve individuals across the age spectrum, including the very young and old, and include considerations of sex/gender, ethnicity, and culture in diverse contexts, beyond Western, Educated, Industrialized, Rich, and Democratic (WEIRD) countries. We conclude with providing directions for future research aimed at improving the well-being of all people impacted by trauma around the world. The 15 years EJPT webinar provides a 90-minute summary of this paper and can be downloaded here [http://bit.ly/4jdtx6k].

28 November 2022 in Sleep Health
Verified
Journal Article
Closed access
DKDavid A. Kalmbach
David A. Kalmbach
PCPhilip Cheng
Philip Cheng
ARAnthony Reffi
Anthony Reffi
GSGrace M. Seymour
Grace M. Seymour
MRMelissa K. Ruprich
Melissa K. Ruprich
Christopher Lawrence DrakeChristopher Lawrence Drake
Christopher Lawrence Drake

11 March 2022 in SLEEP Advances
Verified
Journal Article
Open access
PDF file
DKDavid A Kalmbach
David A Kalmbach
PCPhilip Cheng
Philip Cheng
ARAndrea Roth
Andrea Roth
TRThomas Roth
Thomas Roth
LSLeslie M Swanson
Leslie M Swanson
Christopher Lawrence DrakeChristopher Lawrence Drake
Christopher Lawrence Drake
The study had three primary goals. First, we estimated survey-assessed DSM-5 insomnia disorder rates in pregnancy, and described associated sociodemographics, and sleep-wake and mental health symptoms. Second, we derived cutoffs for detecting DSM-5 insomnia disorder using common self-report measures of sleep symptoms. Third, we identified clinically relevant cut-points on measures of nocturnal cognitive and somatic arousal. Ninety-nine women (85.9% in the 2nd trimester) completed online surveys including DSM-5 insomnia disorder criteria, the Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Presleep Arousal Scale’s Cognitive (PSASC) and Somatic (PSASS) factors, and Edinburgh Postnatal Depression Scale. DSM-5 insomnia disorder rate was 19.2%. Insomnia was associated with depression, suicidality, nocturnal cognitive and somatic arousal, and daytime sleepiness. An ISI scoring method that aligns with DSM-5 criteria yielded excellent metrics for detecting insomnia disorder and good sleep. Regarding quantitative cutoffs, ISI ≥ 10 and ISI ≥ 11 (but not ISI ≥ 15) were supported for detecting DSM-5 insomnia, whereas ISI ≤ 7 and ISI ≤ 9 performed well for detecting good sleep. PSQI cutoff of 5 was supported for detecting insomnia and good sleep. The optimal cutoff for nocturnal cognitive arousal was PSASC ≥ 18, whereas the optimal cutoff for somatic arousal was PSASS ≥ 13. Insomnia disorder affects a large segment of pregnant women. Empirically derived cutoffs for insomnia, good sleep, cognitive arousal, and somatic arousal may inform case identification and future perinatal sleep research methodology.

2 April 2022 in Sleep Medicine
Verified
Journal Article
Closed access
ARAnthony Reffi
Anthony Reffi
DKDavid A. Kalmbach
David A. Kalmbach
PCPhilip Cheng
Philip Cheng
TJTanja P Jovanovic
Tanja P Jovanovic
SNSeth D. Norrholm
Seth D. Norrholm
CDChristopher L. Drake
Christopher L. Drake

5 April 2023 in Journal of Sleep Research
Verified
Journal Article
Closed access
ARAnthony Reffi
Anthony Reffi
DKDavid A. Kalmbach
David A. Kalmbach
PCPhilip Cheng
Philip Cheng
Christopher Lawrence DrakeChristopher Lawrence Drake
Christopher Lawrence Drake